| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/27/2005 | EP1557465A1 Cap-binding protein |
| 07/27/2005 | EP1557409A1 5HT2C receptor modulators |
| 07/27/2005 | EP1557178A1 Use of sglt homolog |
| 07/27/2005 | EP1557175A1 Remedy for bone metabolic diseases |
| 07/27/2005 | EP1557165A1 Combination drug |
| 07/27/2005 | EP1556488A2 Hf-chondroosteomodulin, production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |
| 07/27/2005 | EP1556369A1 Pyridazinone-derivatives as pde4 inhibitors |
| 07/27/2005 | EP1556362A2 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 07/27/2005 | EP1556355A1 Inhibitors of glycogen synthase kinase 3 |
| 07/27/2005 | EP1556353A1 Diaryl compounds as monoamine reuptake inhibitors |
| 07/27/2005 | EP1556351A1 Secondary amino anilinic piperidines as mch1 antagonists and uses thereof |
| 07/27/2005 | EP1556344A1 Treating syndrome x with substituted tetralins and indanes |
| 07/27/2005 | EP1556339A2 Carboxyalkoxy-substituted acyl-carboxyphenyl-urea derivatives, production method and use thereof as medicine |
| 07/27/2005 | EP1556321A2 Policosanol compositions, extraction from novel sources, and uses thereof |
| 07/27/2005 | EP1556140A2 Novel compounds |
| 07/27/2005 | EP1556085A2 Compounds for the treatment of metabolic disorders |
| 07/27/2005 | EP1556074A2 Casein derived peptides and uses thereof in therapy |
| 07/27/2005 | EP1556066A2 Compositions and methods of use for a fibroblast growth factor |
| 07/27/2005 | EP1556057A2 Agents and methods for enhancing bone formation |
| 07/27/2005 | EP1556055A2 Use of cyclic nucleotide phosphodiesterase inhibitors having a benzodiazepine structure in therapy |
| 07/27/2005 | EP1556040A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2 |
| 07/27/2005 | EP1556033A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
| 07/27/2005 | EP1556029A2 Thiomolybdate analogues and uses thereof |
| 07/27/2005 | EP1379523B1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists |
| 07/27/2005 | EP1377573B1 Pyrazolopyridine derivatives |
| 07/27/2005 | EP1351961B1 Substituted indolines as 5-ht receptor ligands |
| 07/27/2005 | EP1339711B1 Aminothiazoles and their use as adenosine receptor antagonists |
| 07/27/2005 | EP1315723B1 The hydrochloride salt of 5[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione |
| 07/27/2005 | EP1289559B1 Combinations of enzyme inhibitor-containing preparations and the use thereof |
| 07/27/2005 | EP1272185B1 Use of quinazoline derivatives as angiogenesis inhibitors |
| 07/27/2005 | EP1263757B1 Benzthiazoles as tnf and pde-iv inhibitors |
| 07/27/2005 | EP1143955B1 A COMBINATION OF FBPase INHIBITORS AND INSULIN SENSITIZERS FOR THE TREATMENT OF DIABETES |
| 07/27/2005 | EP1071403B1 Pharmaceutical composition containing a statin and aspirin |
| 07/27/2005 | EP0973705B1 Chromatographic enantiomer separation of lactones |
| 07/27/2005 | CN1646689A Novel scavenger receptors |
| 07/27/2005 | CN1646538A Topiramate salts and compositions comprising and methods of making and using the same |
| 07/27/2005 | CN1646537A Phosphorus-containing compounds & uses thereof |
| 07/27/2005 | CN1646535A Pyrrolopyrimidine derivative |
| 07/27/2005 | CN1646533A 1-[alkyl], 1-[heteroaryl]alkyl] and 1-[aryl]alkyl]-7-(pyrimidin-4-yl)-imadazo[1, 2-a]pyrimidin-5(1H)-one derivatives |
| 07/27/2005 | CN1646528A Polycyclic compounds as potent alpha2-adrenoceptor antagonists |
| 07/27/2005 | CN1646526A Tropane derivatives as CCR5 modulators |
| 07/27/2005 | CN1646520A 1, 3, 5-triazine derivatives as ligands for human adenosine-A3 receptors |
| 07/27/2005 | CN1646516A Imidazolinylmethyl aralkylsulfonamides |
| 07/27/2005 | CN1646515A Medicinal composition for improving angiotension-regulating function of blood vessel endothelium |
| 07/27/2005 | CN1646508A 5-substituted 1, 1-dioxo-1, 2, 5-thiazolidine-3-one derivatives as PTP ase 1B inhibitors |
| 07/27/2005 | CN1646504A Substituted benzoxazoles and analogues as estrogenic agents |
| 07/27/2005 | CN1646500A Aryl substituted pyrimidines and the use thereof |
| 07/27/2005 | CN1646499A Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient |
| 07/27/2005 | CN1646497A New aryl imidazoles and related compounds as C5a receptor modulators |
| 07/27/2005 | CN1646493A 5HT2C receptor modulators |
| 07/27/2005 | CN1646492A Chain oligolactic acid thioester |
| 07/27/2005 | CN1646490A Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation, as well as novel processes for preparing atorvastatin hemi-calcium forms I, VIII and IX |
| 07/27/2005 | CN1646486A Acyl-3-carboxyphenylurea derivatives, method for production and use thereof |
| 07/27/2005 | CN1646485A Acyl-4-carboxyphenylurea derivatives, method for production and use thereof |
| 07/27/2005 | CN1646481A Crystal forms of N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanine |
| 07/27/2005 | CN1646167A Treatment of metabolic syndrome |
| 07/27/2005 | CN1646165A Combinations of peroxisome proliferator-activated receptor (PPAR) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 07/27/2005 | CN1646162A Use of an inhibitor or antagonist against tissue factor |
| 07/27/2005 | CN1646143A Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders |
| 07/27/2005 | CN1646141A Modified nucleosides for treatment of viral infections and abnormal cellular proliferation |
| 07/27/2005 | CN1646139A Use of pyrimidine nucleotides for the treatment of affections of the peripheral nervous system |
| 07/27/2005 | CN1646138A Novel therapeutical use of agonist ligands specific to G2A receptor |
| 07/27/2005 | CN1646137A Method for treating and preventing hyperparathyroidism |
| 07/27/2005 | CN1646136A Pharmaceutical compositions comprising active vitamin D compounds |
| 07/27/2005 | CN1646131A Novel compounds |
| 07/27/2005 | CN1646111A Novel association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases |
| 07/27/2005 | CN1646109A Methods for preventing and treating peripheral neuropathy by administering desmethylselegiline |
| 07/27/2005 | CN1646106A Capsule preparation |
| 07/27/2005 | CN1646032A Compositions comprising short and long chain fatty acids and methods of their use for the management of body weight |
| 07/27/2005 | CN1644214A YG and YGG used as maintenance and improvement of immunoreaction |
| 07/27/2005 | CN1644203A Oral preparation of red common stone crop polysaccharide and its making method |
| 07/27/2005 | CN1212329C Matching substance with flavone contained in erigeron breviscapus as ligand and its usage |
| 07/27/2005 | CN1212144C Health care food and its preparation |
| 07/27/2005 | CN1212129C Pills for inducing insulin synthesis and their preparation |
| 07/27/2005 | CN1212125C Strontium-calcium composite tonic series and its preparation |
| 07/27/2005 | CN1212123C Fat-binding polymers |
| 07/27/2005 | CN1212117C Medicine composition for treating diabetes mellitus |
| 07/27/2005 | CN1212115C Water soluble vitamin product coated with micro capsule and its producing method |
| 07/27/2005 | CN1212082C Hypolipemic health-care beverage and its preparing method |
| 07/27/2005 | CN1212080C Composition containing fat-soluble vitamins |
| 07/26/2005 | US6921823 1,2,3,4,5,6-Hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position |
| 07/26/2005 | US6921821 Antagonists of melanin concentrating hormone receptor |
| 07/26/2005 | US6921777 E.g., ethyl 3-methyl-5-(,5,8,8-tetra-methyl-5,6,7,8-tetra-hydronaphthalen-2 -ylselenyl)pent-2-en-4-ynoate; dermatological, rheumatic, respiratory, cardiovascular and ophthalmological uses as well as cosmetic uses |
| 07/26/2005 | US6921763 Protein kinase inhibitors |
| 07/26/2005 | US6921762 Substituted indolizine-like compounds and methods of use |
| 07/26/2005 | US6921536 Lawsonia intracellularis vaccine |
| 07/26/2005 | CA2470200C Pharmaceutical composition |
| 07/26/2005 | CA2363902C Process and system for controlled-release drug delivery |
| 07/26/2005 | CA2315481C Selective inhibition of aggrecanase in osteoarthritis treatment |
| 07/26/2005 | CA2233108C Complex of y-cyclodextrin and retinol or retinol derivatives, processes for their preparation and their use |
| 07/26/2005 | CA2149007C Cyclohexane derivatives, process for their preparation, and the use of the compounds for the treatment of diseases |
| 07/26/2005 | CA2112011C Substituted pyridines |
| 07/21/2005 | WO2005066132A1 Therapeutic agents i |
| 07/21/2005 | WO2005065703A1 Novel use of ligand to gpr103-like receptor protein |
| 07/21/2005 | WO2005065700A1 Life-prolonging agent comprising polished rice-origin components as the active ingredient |
| 07/21/2005 | WO2005065675A1 Method of treatment |
| 07/21/2005 | WO2005065465A1 Functional component-enriched barley malt rootlets and process for producing the same |
| 07/21/2005 | WO2005047455A3 Methods for the production of apolipoproteins in transgenic plants |
| 07/21/2005 | WO2002000207A9 The controlled release preparation of insulin and its method |
| 07/21/2005 | US20050159598 Activators of human peroxisome proliferator activated receptors such as {2-[2-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-1,3-thiazol-5-yl}methanol |